Screener
Vaxcyte, Inc. PCVX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $312.78M+111% | $242.06M+81.2% | $209.93M+79.5% | $194.18M+47.7% | $148.13M+56.6% | ||
| $33.07M+1.3% | $32.22M+12.8% | $32.45M+41.1% | $32.04M+49.2% | $32.66M+64.2% | ||
| $345.85M+91.3% | $274.28M+69.1% | $242.38M+73.2% | $226.22M+47.9% | $180.79M+57.9% | ||
| -$345.85M-91.3% | -$274.28M-69.1% | -$242.38M-73.2% | -$226.22M-47.9% | -$180.79M-57.9% | ||
| $25.23M-37.0% | $27.78M+10.7% | $29.55M-19.7% | $59.65M+146% | $40.08M+106% | ||
| -$320.62M-128% | -$246.51M-79.8% | -$212.83M-106% | -$166.57M-29.4% | -$140.72M-48.1% | ||
| -$2.30-121% | -$1.80-76.5% | -$1.56-88.0% | -$1.22-10.9% | -$1.04-22.4% | ||
| -$342.9M-92.8% | -$266.79M-67.5% | -$239.32M-73.2% | -$223.34M-47.3% | -$177.84M-56.7% | ||
| -$345.85M-91.3% | -$274.28M-69.1% | -$242.38M-73.2% | -$226.22M-47.9% | -$180.79M-57.9% |
FAQ
- Is Vaxcyte, Inc. profitable?
- Vaxcyte, Inc. is not currently profitable: it reported a net loss of $946.5M over the trailing twelve months.
- What is Vaxcyte, Inc.'s earnings per share?
- Vaxcyte, Inc.'s diluted EPS over the trailing twelve months is $-6.88.
- Where does Vaxcyte, Inc.'s income statement data come from?
- Every line is extracted from Vaxcyte, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.